John F. de Groot, M.D.
Glioblastoma Moon Shot
About Dr. de Groot
Dr. de Groot is a physician scientist specializing in neuro-oncology. His clinical expertise is on the diagnosis and management of primary brain tumors. His research is focused on identifying novel approaches to treat high grade glioma and translating these therapies into the clinic.
Fighting Cancer: It's Personal
What’s your Moon Shots focus?
My focus for the Moon Shots program is on longitudinal prospective biospecimen collection, developing microbiome projects in glioblastoma and the development and implementation of novel clinical trials.
What makes the Moon Shots Program stand out?
The Moon Shots program provides strategic funding to support early stage research to identify breakthroughs that can be translated into the clinic. Initial funding is often a challenge for new concepts, so having a specific allocation of resources for early stage development is critical to and a validation of the work we are doing.
What motivates and excites you?
I have the distinction of working with a really outstanding team of
research specialists and care providers, particularly in our
commitment to training the next generation. It’s such a thrill to see
people come into their own and just take off with a new idea. The
passion, talent and creativity at MD Anderson is world class.
What makes your fight against cancer personal?
My patients are my #1 motivation for everything I do. I’ve had the
privilege to care for thousands of patients during my career. Their
courage and perseverance with this challenging diagnosis is both
humbling and inspiring. I am always striving to be better, to do
better, for them.
What do you hope to accomplish?
To improve the survival and quality of life for patients with primary brain tumors.
What else do you want people to know about you and your work?
Nobody is a statistic. Everybody is an individual. And while we may not be in control of how the brain tumor behaves, we are in control of how it gets treated. Meaningful hope is living as long as you can and the best you can, and we have the tools to help patients be able to do that.